Sima C - Search Results

1

Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials.

Bailey CH, Jameson G, Sima C, Fleck S, White E, Von Hoff DD, Weiss GJ. Bailey CH, et al. Among authors: sima c. J Cancer. 2012;3:7-13. doi: 10.7150/jca.3.7. Epub 2011 Nov 28. J Cancer. 2012. PMID: 22211140 Free PMC article.

2

Factors influencing time to determination of the recommended phase 2 dose in phase 1 clinical trials.

Caldwell S, Sima C, Jameson G, Fleck S, Weiss GJ. Caldwell S, et al. Among authors: sima c. Am J Clin Oncol. 2013 Apr;36(2):146-50. doi: 10.1097/COC.0b013e31824370a3. Am J Clin Oncol. 2013. PMID: 22314002

3

Determinants of patient screen failures in Phase 1 clinical trials.

Mckane A, Sima C, Ramanathan RK, Jameson G, Mast C, White E, Fleck S, Downhour M, Von Hoff DD, Weiss GJ. Mckane A, et al. Among authors: sima c. Invest New Drugs. 2013 Jun;31(3):774-9. doi: 10.1007/s10637-012-9894-7. Epub 2012 Nov 8. Invest New Drugs. 2013. PMID: 23135779

4

Examining the effect of teleconferences on oncology phase 1 trials.

McKane A, Sima C, Fleck S, Weiss GJ. McKane A, et al. Among authors: sima c. J Cancer. 2013 Jul 4;4(6):464-7. doi: 10.7150/jca.6626. Print 2013. J Cancer. 2013. PMID: 23901345 Free PMC article.

5

Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.

Whitsett TG, Mathews IT, Cardone MH, Lena RJ, Pierceall WE, Bittner M, Sima C, LoBello J, Weiss GJ, Tran NL. Whitsett TG, et al. Among authors: sima c. Mol Cancer Res. 2014 Apr;12(4):550-9. doi: 10.1158/1541-7786.MCR-13-0458. Epub 2014 Jan 27. Mol Cancer Res. 2014. PMID: 24469836 Free PMC article.

6

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer.

Whatcott CJ, Diep CH, Jiang P, Watanabe A, LoBello J, Sima C, Hostetter G, Shepard HM, Von Hoff DD, Han H. Whatcott CJ, et al. Among authors: sima c. Clin Cancer Res. 2015 Aug 1;21(15):3561-8. doi: 10.1158/1078-0432.CCR-14-1051. Epub 2015 Feb 18. Clin Cancer Res. 2015. PMID: 25695692 Free PMC article.

7

miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.

Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. Foss KM, et al. Among authors: sima c. J Thorac Oncol. 2011 Mar;6(3):482-8. doi: 10.1097/JTO.0b013e318208c785. J Thorac Oncol. 2011. PMID: 21258252 Free article.

8

RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.

Arora S, Gonzales IM, Hagelstrom RT, Beaudry C, Choudhary A, Sima C, Tibes R, Mousses S, Azorsa DO. Arora S, et al. Among authors: sima c. Mol Cancer. 2010 Aug 18;9:218. doi: 10.1186/1476-4598-9-218. Mol Cancer. 2010. PMID: 20718987 Free PMC article.

9

An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines.

Saraf RS, Datta A, Sima C, Hua J, Lopes R, Bittner M. Saraf RS, et al. Among authors: sima c. BMC Cancer. 2018 Aug 29;18(1):855. doi: 10.1186/s12885-018-4756-0. BMC Cancer. 2018. PMID: 30157799 Free PMC article.

10

Comprehensive live-cell imaging analysis of cryptotanshinone and synergistic drug-screening effects in various human and canine cancer cell lines.

Bittner ML, Lopes R, Hua J, Sima C, Datta A, Wilson-Robles H. Bittner ML, et al. Among authors: sima c. PLoS One. 2021 Feb 5;16(2):e0236074. doi: 10.1371/journal.pone.0236074. eCollection 2021. PLoS One. 2021. PMID: 33544704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters